ClearPoint Neuro, Inc. (CLPT)
9.14
-0.11
(-1.19%)
USD |
NASDAQ |
Oct 23, 16:00
9.20
+0.06
(+0.66%)
After-Hours: 20:00
ClearPoint Neuro Profit Margin (Quarterly) : -104.2% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -104.2% |
| March 31, 2026 | -78.76% |
| December 31, 2025 | -74.79% |
| September 30, 2025 | -66.48% |
| June 30, 2025 | -63.34% |
| March 31, 2025 | -71.02% |
| December 31, 2024 | -69.31% |
| September 30, 2024 | -61.24% |
| June 30, 2024 | -56.10% |
| March 31, 2024 | -54.27% |
| December 31, 2023 | -67.83% |
| September 30, 2023 | -83.46% |
| June 30, 2023 | -118.5% |
| March 31, 2023 | -103.2% |
| December 31, 2022 | -84.75% |
| September 30, 2022 | -73.61% |
| June 30, 2022 | -82.75% |
| March 31, 2022 | -78.69% |
| December 31, 2021 | -96.89% |
| September 30, 2021 | -87.01% |
| June 30, 2021 | -109.7% |
| March 31, 2021 | -62.98% |
| December 31, 2020 | -42.57% |
| September 30, 2020 | -42.17% |
| June 30, 2020 | -67.04% |
| Date | Value |
|---|---|
| March 31, 2020 | -65.95% |
| December 31, 2019 | -51.26% |
| September 30, 2019 | -38.36% |
| June 30, 2019 | -59.48% |
| March 31, 2019 | -49.37% |
| December 31, 2018 | -53.50% |
| September 30, 2018 | -79.03% |
| June 30, 2018 | -114.0% |
| March 31, 2018 | -101.1% |
| December 31, 2017 | -124.0% |
| September 30, 2017 | -83.02% |
| June 30, 2017 | -101.4% |
| March 31, 2017 | -82.49% |
| December 31, 2016 | -102.8% |
| September 30, 2016 | -158.6% |
| June 30, 2016 | -161.4% |
| March 31, 2016 | -146.6% |
| December 31, 2015 | -79.28% |
| September 30, 2015 | -19.69% |
| June 30, 2015 | -370.6% |
| March 31, 2015 | -390.5% |
| December 31, 2014 | -199.5% |
| September 30, 2014 | -576.0% |
| June 30, 2014 | -134.0% |
| March 31, 2014 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| SINTX Technologies, Inc. | -598.7% |
| Abbott Laboratories | 7.07% |
| AngioDynamics, Inc. | -8.77% |
| Alphatec Holdings, Inc. | -12.07% |
| AtriCure, Inc. | 5.83% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -185.3% |
| Return on Assets | -42.75% |
| Return on Invested Capital | -49.35% |
| Gross Profit Margin (Quarterly) | 59.79% |
| Operating Margin (Quarterly) | -94.15% |
| Return on Net Operating Assets | -85.41% |